A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)
Clinical trial NCT06897527 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06897527
- Sponsor
- GlaxoSmithKline
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-15
- Primary completion
- 2027-01-13
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.